Posts Tagged 'Birth Control Pills'

“Protest The Pill Day” aims to inform women of Yaz, Yasmin blood clots

Saturday, June 7th was “Protest The Pill Day,” an event organized to inform women about the risks associated with birth control pills Yaz and Yasmin. Bayer’s top-selling birth control pills have been linked to an increased risk of blood clots, including deep vein thrombosis, which can cause heart attacks and stroke.

Read more about “Protest The Pill Day”…

Health Canada reviews more birth control pills linked to blood clots

Health Canada is reviewing the connection between a birth control drug and blood clots after France banned it for causing the deaths of 4 women. The drug, Diane-35, is used to treat acne and is prescribed as an oral contraceptive, but may be responsible for deadly blood clots.

Read more about the link between certain birth control pills and blood clots…

 

 

FDA: Novartis Unit Recalling Introvale Birth Control Pills

The U.S. Food and Drug Administration said Wednesday that a Novartis AG unit is recalling a three-month birth-control regimen sold in the U.S. because of a packing error. The recall involves a birth-control pill called Introvale that is marketed by Sandoz. FDA said the recall, which affects 10 lots distributed between January and May 2012, was prompted by a consumer report of the inactive pills being located in the row labeled week nine.

Read more about the birth control recall…

Pfizer recalls 1 million birth control packets

A birth control manufacturer announced that it has recalled about one million packets of birth control pills due to concerns that they may not effectively prevent pregnancy. Pfizer is recalling 14 lots of its Lo/Ovral-28 pills and 14 lots of its generic norgestrel/ethinyl estradiol pills because they may have been manufactured without the correct number of contraceptive pills, putting users at risk of unintended pregnancy.

Click here to read more…

FDA advisers: Ortho Evra patch needs clearer label

U.S. drug advisers recommended that the label for Johnson and Johnson’s Ortho Evra birth control patch be simplified to better explain the risk of blood clots. Advisers to the Food and Drug Administration found that the current label for Ortho Evra inadequately reflects the risks women face by using it. The patch, approved in 2001, has been linked to an even higher risk as it contains a much greater amount of the hormone estrogen than a pill.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.